Glenmark Pharmaceuticals Limited (NSE: GLENMARK)
India flag India · Delayed Price · Currency is INR
1,541.65
+0.85 (0.06%)
Dec 20, 2024, 3:30 PM IST

Glenmark Pharmaceuticals Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019 - 2015
Net Income
-8,752-15,0172,9729,4179,7007,760
Upgrade
Depreciation & Amortization
4,0804,7923,8101,6133,1622,710
Upgrade
Other Amortization
1,5171,5172,3033,2541,2731,461
Upgrade
Loss (Gain) From Sale of Assets
11.96-8.26-57.2564.64-3.54-173.81
Upgrade
Loss (Gain) From Sale of Investments
-7,449-7,450-0.26-149.81-0.34-
Upgrade
Stock-Based Compensation
-58.9749.6267.7479.1679.3730.84
Upgrade
Provision & Write-off of Bad Debts
172.88176.5118.72298.74113.69178.33
Upgrade
Other Operating Activities
10,74015,9281,4992,122845.41686.77
Upgrade
Change in Accounts Receivable
-3,9009,695-8,487-5,493-1,179-2,927
Upgrade
Change in Inventory
-4,673-5,139-3,752-2,034-1,338972.56
Upgrade
Change in Accounts Payable
-5,967-7,3441,662847.571,6051,527
Upgrade
Change in Other Net Operating Assets
-1,081-5,182-167.731,067-2,9461,698
Upgrade
Operating Cash Flow
-13,441-2,6546,25411,08711,31213,924
Upgrade
Operating Cash Flow Growth
---43.59%-1.99%-18.76%5.15%
Upgrade
Capital Expenditures
-7,331-8,984-6,078-7,901-7,748-9,314
Upgrade
Sale of Property, Plant & Equipment
13.3620.8572.2915.8994.331,560
Upgrade
Divestitures
54,49654,496----
Upgrade
Investment in Securities
7,458--10.08-100.18-50
Upgrade
Other Investing Activities
124.2875.82230.514,6530.89-131.75
Upgrade
Investing Cash Flow
54,76145,609-5,285-3,333-6,752-7,835
Upgrade
Short-Term Debt Issued
-4,811--855.711,231
Upgrade
Long-Term Debt Issued
--11,63221,30116,4437,220
Upgrade
Total Debt Issued
6,6204,81111,63221,30117,2998,451
Upgrade
Short-Term Debt Repaid
---200-1,417--
Upgrade
Long-Term Debt Repaid
--37,539-6,198-31,201-18,076-9,197
Upgrade
Total Debt Repaid
-38,706-37,539-6,398-32,618-18,076-9,197
Upgrade
Net Debt Issued (Repaid)
-32,087-32,7285,234-11,317-777.1-746.55
Upgrade
Issuance of Common Stock
1212----
Upgrade
Common Dividends Paid
-703.64-704.52-703.86-926.95-704.47-685.54
Upgrade
Other Financing Activities
-4,213-5,641-5,3057,040-2,936-3,015
Upgrade
Financing Cash Flow
-36,992-39,061-774.56-5,205-4,418-4,447
Upgrade
Foreign Exchange Rate Adjustments
118.67176.79123.87175.5136.2297.64
Upgrade
Miscellaneous Cash Flow Adjustments
-1,918-1,9186.68---
Upgrade
Net Cash Flow
2,5302,1523252,724278.21,740
Upgrade
Free Cash Flow
-20,772-11,638176.293,1853,5654,610
Upgrade
Free Cash Flow Growth
---94.47%-10.64%-22.68%429.93%
Upgrade
Free Cash Flow Margin
-15.88%-9.20%0.15%2.59%3.26%4.33%
Upgrade
Free Cash Flow Per Share
-73.60-41.240.6211.2912.6316.34
Upgrade
Cash Interest Paid
3,7405,1683,1152,5052,9363,015
Upgrade
Cash Income Tax Paid
12,48010,4756,4055,5845,1024,670
Upgrade
Levered Free Cash Flow
34,77143,246-11,6041,8531,1541,392
Upgrade
Unlevered Free Cash Flow
37,08946,471-9,4233,7163,3613,750
Upgrade
Change in Net Working Capital
-27,747-40,06116,6394,8304,132-746.74
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.